Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome

Annals of Hematology

Volumn 82, Issue 5, 2003, Pages 299-302

  Hauser, Anna Christine ^a   Brichta, A ^a   Pabinger Fasching, I ^a   Jager U ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Budd Chiari syndrome; Paroxysmal nocturnal hemoglobinuria; PNH; Recombinant tissue plasminogen activator; Thrombolytic therapy

Indexed keywords

ALTEPLASE; DICOUMAROL;

ADULT; ARTICLE; ASCITES; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEPATOSPLENOMEGALY; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; LABORATORY TEST; LIVER VEIN OBSTRUCTION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RECANALIZATION; VEIN THROMBOSIS;

EID: 0038175940     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0639-8     Document Type: Article

References (36)

1. Rosse WF (1997) Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine 76:63-93
2. Ham TH (1938) Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. A study of the mechanism of hemolysis in relation to acid-base equilibrium. N Engl J Med 217:915
3. Iida Y, Takeda J, Miyata T, Inoue N, Nishimura J, Kitani T, Maeda K, Kinoshita T (1994) Characterization of genomic PIG-A gene: a gene for GPI anchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood 83:3126-3131
4. Navenot JM, Muller JY, Blanchard D (1998) Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes. Transfusion 38:337-342
5. Nafa K, Bessler M, Castro-Malaspina H, Jhanwar S, Luzzatto L (1998) The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis 24:370-384
6. Selvaraj P, Rosse WF, Silber R, Springer TA (1988) The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333:565-570
7. Sugita Y, Nakano Y, Oda E, Tobe T, Miura NH, Tomita M (1993) Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositolanchored membrane protein. J Biochem (Tokyo) 14:473-477
8. Nicholson-Weller A, Burge J, Fearon DT, Weller PF (1982) Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129:184
9. Nicholson-Weller A, Spicer DB, Austen KF (1985) Deficiency of the complement regulatory protein "decay accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. J Med 312:1091-1097
10. Rollins SA, Sims PJ (1990) The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 144:3478-3483
11. Terstappen LW, Nguyen M, Huang S, Lazarus HM, Medof ME (1993) Defective and normal hematopoietic stem cells in paroxysmal nocturnal hemoglobinuria. Br J Haematol 84:504-514
12. Prince GM, Nguyen M, Lazarus HM, Brodsky RA, Terstappen LW, Medof ME (1995) Peripheral blood harvest of unaffected CD34+ CD38- hematopoietic precursors in paroxysmal nocturnal hemoglobinuria. Blood 86:3381-3386
13. Fujioka S, Yamada T (1994) Varying populations of CD59-negative, partly positive, and normally positive blood cells in different cell lineages in peripheral blood of paroxysmal nocturnal hemoglobinuria patients. Am J Hematol 45:122-127
14. Tseng JE, Hall SE, Howard TA, Ware RE (1995) Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. Am J Hematol 50:244-253
15. Aster RH, Enright SE (1969) A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. J Clin Invest 48:1199-1210
16. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E (1996) Paroxysmal nocturnal haemoglobinuria: long term follow-up and prognostic factors. Lancet 348:573-577
17. Valla D, Dhumeaux D, Babany G, Hillon P, Rueff B, Rochant H, Benhamou JP (1987) Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology 93:569-575
18. Okuda K, Kage M, Shrestha SM. (1998) Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at is hepatic portion. Hepatology 28:1191-1198
19. Yang XL, Cheng TO, Chen CR (1996) Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol 28:1720
20. Witte AM, Kool LJ, Veenendaal R, Lamers CB, van Hoek B (1997) Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol 92:498-501
21. Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, Gerok W, Rossle M (1993) Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18:217-225
22. McDermott WV, Stone MD, Bothe A Jr, Trey C (1984) Budd-Chiari syndrome: historical and clinical review with an analysis of surgical corrective procedures. Am J Surg 147:463-467
23. Orloff MJ, Johansen KH (1978) Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: experimental and clinical results. Ann Surg 188:494-512
24. Cameron JL, Herlong HF, Sanfey H, Boitnott J, Kaufman SL, Gott VL, Maddrey WC (1983) The Budd-Chiari syndrome: treatment by mesenteric-systemic venous shunts. Ann Surg 19:335-346
25. Kugelmas M (1998) Budd-Chiari syndrome. Treatment options and the value of liver transplantation. Hepatogastroenterology 45:1381-1386
26. Hartmann RC, Jenkins DE Jr (1965) The "sugar water" test for paroxysmal nocturnal hemoglobinuria. N Engl J Med 275:155-157
27. Gupta S, Barter S, Phillips GWL, et al. (1987) Comparison of ultrasonography, computed tomography and 99mTC liver scan diagnosis of Budd-Chiari syndrome. Gut 28:242-247
28. Trotman BW (1991) Pigment gallstone disease. Gastroenterol Clin North Am 20:111-126
29. Powell-Jackson PR, Melia W, Canalese J, Pickford RB, Portmann B, Williams R (1982) Budd-Chiari syndrome: clinical patterns and therapy. Q J Med. 51:79-88
30. Leebeek FW, Lameris JS, van Buuren HR, Gomez E, Madretsma S, Sonneveld P (1998) Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis. Br J Haematol 102:929-931
31. McMullin MF, Hillmen P, Jackson J, Ganly P, Luzzatto L (1994) Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med 235:85-89
32. Mahmoud AE, Mendoza A, Meshikhes AN, Olliff S, West R, Neuberger J, Buckels J, Wilde J, Elias E (1996) Clinical spectrum, investigations, and treatment of Budd-Chiari syndrome. QJM 89:37-42
33. Panis Y, Benghiti J, Valla D, Benhamou JP, Fekete F (1994) Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 115:276-281
34. Raju G, Felver M, Olin JW, Satti SD (1996) Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. Am J Gastroenterol 91:1262-1263
35. Greenwood LH, Yrizarry JM, Hallett JW Jr, Scoville GS Jr (1983) Urokinase treatment of Budd-Chiari syndrome. AJR Am J Roentgenol 141:1057-1059
36. Sholar PW, Bell WR (1985) Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med 103:539-541